Publications by authors named "Jane Leonard"

Claim this Profile
P
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.
Benjamin T Cooper, Wade T Iams, David B Page, Yuan Yuan, Naamit K Gerber, E Jane Leonard

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor.
José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo, Yolanda Jerez, Ainhara Lahuerta, E Jane Leonard

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey.
Rajib Lodh, Sam Amin, Amr Ammar, Lucy Bellis, Phillip Brink, Jane Leonard

Arch Dis Child· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of malnutrition in children with autism spectrum disorder.
Lydia Iris Healy, Eimear Forbes, Jane Rice, Jane M Leonard, Ellen Crushell

Arch Dis Child Educ Pract Ed· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Bora Lim, David A Potter, Mohamad A Salkeni, Paula Silverman, Tufia C Haddad, E Jane Leonard

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The short-term effects of selective dorsal rhizotomy on gait compared to matched cerebral palsy control groups.
Rory O'Sullivan, Jane Leonard, Aoife Quinn, Damien Kiernan

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, Tibor Csoszi, Gyula Ostoros, E Jane Leonard

J Thorac Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, Josep M Roncero, Judith Trotman, John P Leonard, E Jane Leonard

J Clin Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.
Gerald Falchook, Robert L Coleman, Andrzej Roszak, Kian Behbakht, Ursula Matulonis, E Jane Leonard

JAMA Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
Kevin R Kelly, Jonathan W Friedberg, Steven I Park, Kevin McDonagh, John Hayslip, E Jane Leonard

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the Spectrum of Post-malaria Neurologic Syndrome in the Pediatric Population.
Robert J Kernan, Patrick J Gavin, Karina M Butler, T Ronan Leahy, Bryan Lynch, Jane Leonard

Pediatr Infect Dis J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors.
Julie N Graff, Celestia S Higano, Noah M Hahn, Matthew H Taylor, Bin Zhang, E Jane Leonard

Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe combined immunodeficiency syndrome presenting with disseminated BCG infection.
Patrick Fitzpatrick, Jane Leonard, Eilis Twomey, Andrea Malone, Zohreh Nademi

Arch Dis Child· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes.
Stuart L Goldberg, Pierre Fenaux, Michael D Craig, Emmanuel Gyan, John Lister, E Jane Leonard

Leuk Res Rep· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas.
Jonathan W Friedberg, Daruka Mahadevan, Erin Cebula, Daniel Persky, Izidore Lossos, E Jane Leonard

J Clin Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute functional deterioration in a child with cerebral palsy.
Elizabeth Smyth, Chandrasekaran Kaliaperumal, Jane Leonard, John Caird

BMJ Case Rep· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should children with cerebral palsy and normal imaging undergo testing for inherited metabolic disorders?
Jane M Leonard, Alison L Cozens, Susan M Reid, Michael C Fahey, Michael R Ditchfield

Dev Med Child Neurol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PlayStation purpura.
Susan J Robertson, Jane Leonard, Alex J Chamberlain

Australas J Dermatol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis